True North Advisors, LLC Sanofi Transaction History

True North Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $764,302 - $907,463	-16,666 Reduced 33.29%	33,394 $1.82 Million
Q1 2022 May 12, 2022	BUY	$48.48 - $53.65 $483,006 - $534,514	9,963 Added 24.85%	50,060 $2.57 Million
Q4 2021 Feb 11, 2022	BUY	$47.07 - $52.35 $498,283 - $554,177	10,586 Added 35.87%	40,097 $2.01 Million
Q3 2021 Jun 07, 2022	BUY	$47.89 - $53.12 $383 - $424	8 Added 0.03%	29,511 $1.42 Million
Q2 2021 Jun 07, 2022	BUY	$49.36 - $54.25 $49 - $54	1 Added 0.0%	29,503 $1.55 Million
Q1 2021 Jun 07, 2022	SELL	$45.46 - $50.51 $681 - $757	-15 Reduced 0.05%	29,502 $1.46 Million
Q4 2020 May 20, 2022	SELL	$45.3 - $51.62 $12,276 - $13,989	-271 Reduced 0.91%	29,517 $1.43 Million
Q3 2020 May 20, 2022	BUY	$49.47 - $53.77 $16,424 - $17,851	332 Added 1.13%	29,788 $1.49 Million
Q2 2020 May 20, 2022	BUY	$42.91 - $52.5 $1.26 Million - $1.55 Million	29,456 New	29,456 $1.5 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.